Verve Therapeutics
About Us
Why Heart Disease
Approach
Culture & Careers
News
Contact Us
With a superstar cardiologist as its CEO, new CRISPR company targets heart disease
Post navigation
Previous Post
Previous
One of the world’s top experts in coronary heart disease is spearheading a new gene editing upstart out to transform the field
Next Post
Next
One-off injection may drastically reduce heart attack risk
Home
About Us
Why Heart Disease
Approach
Culture & Careers
News
Contact Us